{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:34:54Z","timestamp":1790825694944,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH048404"],"award-info":[{"award-number":["R01-MH048404"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH048404"],"award-info":[{"award-number":["R01-MH048404"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH048404"],"award-info":[{"award-number":["R01-MH048404"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH048404"],"award-info":[{"award-number":["R01-MH048404"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH048404"],"award-info":[{"award-number":["R01-MH048404"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIA-MH002983"],"award-info":[{"award-number":["ZIA-MH002983"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH048404"],"award-info":[{"award-number":["MH048404"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32-AA746834"],"award-info":[{"award-number":["T32-AA746834"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F32-DA060070"],"award-info":[{"award-number":["F32-DA060070"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32-DA007262"],"award-info":[{"award-number":["T32-DA007262"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41380-026-03632-1","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:54:30Z","timestamp":1778698470000},"page":"5474-5485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Grin2a knockout in adolescent dopamine neurons disrupts prediction error signaling and produces a phenotype relevant to schizophrenia"],"prefix":"10.1038","volume":"31","author":[{"given":"Michelle L.","family":"Kielhold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Torrado Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merridee J.","family":"Lefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina P.","family":"Bogachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Lebowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Langdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-6144","authenticated-orcid":false,"given":"John T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-5331","authenticated-orcid":false,"given":"Larry S.","family":"Zweifel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-417X","authenticated-orcid":false,"given":"Bita","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3632_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","volume":"37","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37:4\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"3632_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1176\/appi.ajp.2020.20101481","volume":"177","author":"JT Coyle","year":"2020","unstructured":"Coyle JT, Ruzicka WB, Balu DT. Fifty years of research on schizophrenia: the ascendance of the glutamatergic synapse. Am J Psychiatry. 2020;177:1119\u201328.","journal-title":"Am J Psychiatry"},{"key":"3632_CR3","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","volume":"12","author":"AJ Law","year":"2001","unstructured":"Law AJ, Deakin JF. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport. 2001;12:2971\u20134.","journal-title":"Neuroreport"},{"key":"3632_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/mp.2012.137","volume":"18","author":"CS Weickert","year":"2013","unstructured":"Weickert CS, Fung SJ, Catts VS, Schofield PR, Allen KM, Moore LT, et al. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry. 2013;18:1185\u201392.","journal-title":"Mol Psychiatry"},{"key":"3632_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1196\/annals.1300.005","volume":"1003","author":"JH Meador-Woodruff","year":"2003","unstructured":"Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci. 2003;1003:75\u201393.","journal-title":"Ann N Y Acad Sci"},{"key":"3632_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301\u20138.","journal-title":"Am J Psychiatry"},{"key":"3632_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/schbul\/sbs075","volume":"38","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam B, Krystal JH. Capturing the angel in \u201cangel dust\u201d: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull. 2012;38:942\u20139.","journal-title":"Schizophr Bull"},{"key":"3632_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","volume":"604","author":"T Singh","year":"2022","unstructured":"Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604:509\u201316.","journal-title":"Nature"},{"key":"3632_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics C","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"3632_CR10","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/ng.2742","volume":"45","author":"S Ripke","year":"2013","unstructured":"Ripke S, O\u2019Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150\u20139.","journal-title":"Nat Genet"},{"key":"3632_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature08186","volume":"460","author":"H Stefansson","year":"2009","unstructured":"Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744\u20137.","journal-title":"Nature"},{"key":"3632_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardinas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","journal-title":"Nature"},{"key":"3632_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.biopsych.2021.10.018","volume":"91","author":"J Hall","year":"2022","unstructured":"Hall J, Bray NJ. Schizophrenia genomics: convergence on synaptic development, adult synaptic plasticity, or both? Biol Psychiatry. 2022;91:709\u201317.","journal-title":"Biol Psychiatry"},{"key":"3632_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41380-025-03279-4","volume":"31","author":"JR Lemke","year":"2025","unstructured":"Lemke JR, Eoli A, Krey I, Popp B, Strehlow V, Wittekind DA, et al. GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy. Mol Psychiatry. 2025;31:374\u201382.","journal-title":"Mol Psychiatry"},{"key":"3632_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.schres.2016.03.032","volume":"174","author":"K Ohi","year":"2016","unstructured":"Ohi K, Shimada T, Nitta Y, Kihara H, Okubo H, Uehara T, et al. Specific gene expression patterns of 108 schizophrenia-associated loci in cortex. Schizophr Res. 2016;174:35\u201338.","journal-title":"Schizophr Res"},{"key":"3632_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"J van Os","year":"2009","unstructured":"van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635\u201345.","journal-title":"Lancet"},{"key":"3632_CR17","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.4088\/JCP.13078tx2c","volume":"75","author":"A Abi-Dargham","year":"2014","unstructured":"Abi-Dargham A. Schizophrenia: overview and dopamine dysfunction. J Clin Psychiatry. 2014;75:e31.","journal-title":"J Clin Psychiatry"},{"key":"3632_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016;17:524\u201332.","journal-title":"Nat Rev Neurosci"},{"key":"3632_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/ajp.155.6.761","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998;155:761\u20137.","journal-title":"Am J Psychiatry"},{"key":"3632_CR20","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97:8104\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3632_CR21","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/brain\/awt264","volume":"136","author":"OD Howes","year":"2013","unstructured":"Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 2013;136:3242\u201351.","journal-title":"Brain"},{"key":"3632_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41386-021-01188-y","volume":"47","author":"SJ Millard","year":"2022","unstructured":"Millard SJ, Bearden CE, Karlsgodt KH, Sharpe MJ. The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity. Neuropsychopharmacology. 2022;47:628\u201340.","journal-title":"Neuropsychopharmacology"},{"key":"3632_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/schbul\/sbaa055","volume":"46","author":"T Katthagen","year":"2020","unstructured":"Katthagen T, Kaminski J, Heinz A, Buchert R, Schlagenhauf F. Striatal dopamine and reward prediction error signaling in unmedicated schizophrenia patients. Schizophr Bull. 2020;46:1535\u201346.","journal-title":"Schizophr Bull"},{"key":"3632_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/mp.2011.75","volume":"17","author":"RW Morris","year":"2012","unstructured":"Morris RW, Vercammen A, Lenroot R, Moore L, Langton JM, Short B, et al. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatry. 2012;17:280\u2013239. 235","journal-title":"Mol Psychiatry"},{"issue":"Pt 9","key":"3632_CR25","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/brain\/awm173","volume":"130","author":"PR Corlett","year":"2007","unstructured":"Corlett PR, Murray GK, Honey GD, Aitken MR, Shanks DR, Robbins TW, et al. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain. 2007;130(Pt 9):2387\u20132400.","journal-title":"Brain"},{"key":"3632_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/sj.mp.4002058","volume":"13","author":"GK Murray","year":"2008","unstructured":"Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, et al. Substantia nigra\/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry. 2008;13:267\u201376. 239","journal-title":"Mol Psychiatry"},{"key":"3632_CR27","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41386-018-0056-2","volume":"43","author":"AO Ermakova","year":"2018","unstructured":"Ermakova AO, Knolle F, Justicia A, Bullmore ET, Jones PB, Robbins TW, et al. Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis. Neuropsychopharmacology. 2018;43:1691\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"3632_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0250-3","volume":"8","author":"F Knolle","year":"2018","unstructured":"Knolle F, Ermakova AO, Justicia A, Fletcher PC, Bunzeck N, Duzel E, et al. Brain responses to different types of salience in antipsychotic naive first episode psychosis: an fMRI study. Transl Psychiatry. 2018;8:196.","journal-title":"Transl Psychiatry"},{"key":"3632_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1503\/jpn.140383","volume":"41","author":"M Kirschner","year":"2016","unstructured":"Kirschner M, Hager OM, Bischof M, Hartmann MN, Kluge A, Seifritz E, et al. Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia. J Psychiatry Neurosci. 2016;41:152\u201361.","journal-title":"J Psychiatry Neurosci"},{"key":"3632_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","volume":"158","author":"S Kapur","year":"2001","unstructured":"Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158:360\u20139.","journal-title":"Am J Psychiatry"},{"key":"3632_CR31","first-page":"200","volume":"32","author":"S Matthysse","year":"1973","unstructured":"Matthysse S. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc. 1973;32:200\u20135.","journal-title":"Fed Proc"},{"key":"3632_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5498\/wjp.v11.i7.355","volume":"11","author":"MV Seeman","year":"2021","unstructured":"Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatry. 2021;11:355\u201364.","journal-title":"World J Psychiatry"},{"key":"3632_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/261717a0","volume":"261","author":"P Seeman","year":"1976","unstructured":"Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic\/dopamine receptors. Nature. 1976;261:717\u20139.","journal-title":"Nature"},{"key":"3632_CR34","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1016\/j.neuron.2023.08.004","volume":"111","author":"Z Farsi","year":"2023","unstructured":"Farsi Z, Nicolella A, Simmons SK, Aryal S, Shepard N, Brenner K, et al. Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice. Neuron. 2023;111:3378\u20133396.e9.","journal-title":"Neuron"},{"key":"3632_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02393-7","volume":"13","author":"LE Herzog","year":"2023","unstructured":"Herzog LE, Wang L, Yu E, Choi S, Farsi Z, Song BJ, et al. Mouse mutants in schizophrenia risk genes GRIN2A and AKAP11 show EEG abnormalities in common with schizophrenia patients. Transl Psychiatry. 2023;13:92.","journal-title":"Transl Psychiatry"},{"key":"3632_CR36","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s42003-023-05298-9","volume":"6","author":"CR Camp","year":"2023","unstructured":"Camp CR, Vlachos A, Klockner C, Krey I, Banke TG, Shariatzadeh N, et al. Loss of Grin2a causes a transient delay in the electrophysiological maturation of hippocampal parvalbumin interneurons. Commun Biol. 2023;6:952.","journal-title":"Commun Biol"},{"key":"3632_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105045","volume":"102","author":"Y Lu","year":"2024","unstructured":"Lu Y, Mu L, Elstrott J, Fu C, Sun C, Su T, et al. Differential depletion of GluN2A induces heterogeneous schizophrenia-related phenotypes in mice. EBioMedicine. 2024;102:105045.","journal-title":"EBioMedicine"},{"key":"3632_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/373151a0","volume":"373","author":"K Sakimura","year":"1995","unstructured":"Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature. 1995;373:151\u20135.","journal-title":"Nature"},{"key":"3632_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1192\/S0007125000071919","volume":"137","author":"TJ Crow","year":"1980","unstructured":"Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry. 1980;137:383\u20136.","journal-title":"Br J Psychiatry"},{"key":"3632_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2018.08.018","volume":"204","author":"G Carra","year":"2019","unstructured":"Carra G, Crocamo C, Angermeyer M, Brugha T, Toumi M, Bebbington P. Positive and negative symptoms in schizophrenia: a longitudinal analysis using latent variable structural equation modelling. Schizophr Res. 2019;204:58\u201364.","journal-title":"Schizophr Res"},{"key":"3632_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/archpsyc.1995.03950140045005","volume":"52","author":"WW Eaton","year":"1995","unstructured":"Eaton WW, Thara R, Federman B, Melton B, Liang KY. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry. 1995;52:127\u201334.","journal-title":"Arch Gen Psychiatry"},{"key":"3632_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.neuron.2011.10.028","volume":"72","author":"IB Witten","year":"2011","unstructured":"Witten IB, Steinberg EE, Lee SY, Davidson TJ, Zalocusky KA, Brodsky M, et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron. 2011;72:721\u201333.","journal-title":"Neuron"},{"key":"3632_CR43","doi-asserted-by":"crossref","unstructured":"Lefner MJ, Moghaddam B. Flexible updating of reward and punishment contingencies by VTA GABA neurons. Curr Biol. 2025;35:3973\u201385.e3.","DOI":"10.1016\/j.cub.2025.07.021"},{"key":"3632_CR44","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41386-018-0088-7","volume":"43","author":"S Lohani","year":"2018","unstructured":"Lohani S, Martig AK, Underhill SM, DeFrancesco A, Roberts MJ, Rinaman L, et al. Burst activation of dopamine neurons produces prolonged post-burst availability of actively released dopamine. Neuropsychopharmacology. 2018;43:2083\u201392.","journal-title":"Neuropsychopharmacology"},{"key":"3632_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/mp.2016.102","volume":"22","author":"S Lohani","year":"2017","unstructured":"Lohani S, Poplawsky AJ, Kim SG, Moghaddam B. Unexpected global impact of VTA dopamine neuron activation as measured by opto-fMRI. Mol Psychiatry. 2017;22:585\u201394.","journal-title":"Mol Psychiatry"},{"key":"3632_CR46","doi-asserted-by":"publisher","unstructured":"Wager-Miller J, Murphy Green M, Shafique H, Mackie K. Collection of frozen rodent brain regions for downstream analyses. J Vis Exp 2020; https:\/\/doi.org\/10.3791\/60474","DOI":"10.3791\/60474"},{"key":"3632_CR47","volume-title":"A stereotaxic atlas of the rat brain","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C. A stereotaxic atlas of the rat brain. New York: Academic; 1998."},{"key":"3632_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/978-1-0716-1186-9_30","volume":"2261","author":"C Luck","year":"2021","unstructured":"Luck C, Haitjema C, Heger C. Simple western: bringing the western blot into the twenty-first century. Methods Mol Biol. 2021;2261:481\u20138.","journal-title":"Methods Mol Biol"},{"key":"3632_CR49","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1016\/j.celrep.2020.02.092","volume":"30","author":"AC Hunker","year":"2020","unstructured":"Hunker AC, Soden ME, Krayushkina D, Heymann G, Awatramani R, Zweifel LS. Conditional single vector CRISPR\/SaCas9 viruses for efficient mutagenesis in the adult mouse nervous system. Cell Rep. 2020;30:4303\u20134316.e6.","journal-title":"Cell Rep"},{"key":"3632_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1037\/h0043788","volume":"48","author":"KC Montgomery","year":"1955","unstructured":"Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1955;48:254\u201360.","journal-title":"J Comp Physiol Psychol"},{"key":"3632_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol Biol. 2019;1916:105\u201311.","journal-title":"Methods Mol Biol"},{"key":"3632_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","volume":"66","author":"NR Richardson","year":"1996","unstructured":"Richardson NR, Roberts DC. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods. 1996;66:1\u201311.","journal-title":"J Neurosci Methods"},{"key":"3632_CR53","doi-asserted-by":"publisher","first-page":"e29766","DOI":"10.1371\/journal.pone.0029766","volume":"7","author":"Y Kim","year":"2012","unstructured":"Kim Y, Wood J, Moghaddam B. Coordinated activity of ventral tegmental neurons adapts to appetitive and aversive learning. PLoS One. 2012;7:e29766.","journal-title":"PLoS One"},{"key":"3632_CR54","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/j.1460-9568.2010.07371.x","volume":"32","author":"YB Kim","year":"2010","unstructured":"Kim YB, Matthews M, Moghaddam B. Putative gamma-aminobutyric acid neurons in the ventral tegmental area have a similar pattern of plasticity as dopamine neurons during appetitive and aversive learning. Eur J Neurosci. 2010;32:1564\u201372.","journal-title":"Eur J Neurosci"},{"key":"3632_CR55","unstructured":"Rescorla RA, Wagner AR A theory of Pavlovian conditioning: Variations in the effectiveness of reinforcement and nonreinforcement. In: Black AHP, WF (ed). Classical conditioning II: Current research and theory. Appleton-Century-Crofts: New York, 1972, pp 64\u201399."},{"key":"3632_CR56","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1037\/0033-295X.87.6.532","volume":"87","author":"JM Pearce","year":"1980","unstructured":"Pearce JM, Hall G. A model for pavlovian learning: variations in the effectiveness of conditioned but not of unconditioned stimuli. Psychol Rev. 1980;87:532\u201352.","journal-title":"Psychol Rev"},{"key":"3632_CR57","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/j.1460-9568.2011.07986.x","volume":"35","author":"MR Roesch","year":"2012","unstructured":"Roesch MR, Esber GR, Li J, Daw ND, Schoenbaum G. Surprise! neural correlates of pearce-hall and rescorla-wagner coexist within the brain. Eur J Neurosci. 2012;35:1190\u20131200.","journal-title":"Eur J Neurosci"},{"key":"3632_CR58","doi-asserted-by":"publisher","first-page":"e1004559","DOI":"10.1371\/journal.pcbi.1004559","volume":"11","author":"O Bar-Shira","year":"2015","unstructured":"Bar-Shira O, Maor R, Chechik G. Gene expression switching of receptor subunits in human brain development. PLoS Comput Biol. 2015;11:e1004559.","journal-title":"PLoS Comput Biol"},{"key":"3632_CR59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","volume":"12","author":"H Monyer","year":"1994","unstructured":"Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12:529\u201340.","journal-title":"Neuron"},{"key":"3632_CR60","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/00001756-199212000-00027","volume":"3","author":"M Watanabe","year":"1992","unstructured":"Watanabe M, Inoue Y, Sakimura K, Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport. 1992;3:1138\u201340.","journal-title":"Neuroreport"},{"key":"3632_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00001756-199512000-00010","volume":"7","author":"A Wenzel","year":"1995","unstructured":"Wenzel A, Scheurer L, Kunzi R, Fritschy JM, Mohler H, Benke D. Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. Neuroreport. 1995;7:45\u201348.","journal-title":"Neuroreport"},{"key":"3632_CR62","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.biopsych.2006.05.008","volume":"59","author":"CM Powell","year":"2006","unstructured":"Powell CM, Miyakawa T. Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry. 2006;59:1198\u2013207.","journal-title":"Biol Psychiatry"},{"key":"3632_CR63","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2174\/138161212799958576","volume":"18","author":"C Bondi","year":"2012","unstructured":"Bondi C, Matthews M, Moghaddam B. Glutamatergic animal models of schizophrenia. Curr Pharm Des. 2012;18:1593\u2013604.","journal-title":"Curr Pharm Des"},{"key":"3632_CR64","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.schres.2015.12.017","volume":"170","author":"JM McCarthy","year":"2016","unstructured":"McCarthy JM, Treadway MT, Bennett ME, Blanchard JJ. Inefficient effort allocation and negative symptoms in individuals with schizophrenia. Schizophr Res. 2016;170:278\u201384.","journal-title":"Schizophr Res"},{"key":"3632_CR65","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.schres.2014.11.024","volume":"161","author":"MT Treadway","year":"2015","unstructured":"Treadway MT, Peterman JS, Zald DH, Park S. Impaired effort allocation in patients with schizophrenia. Schizophr Res. 2015;161:382\u20135.","journal-title":"Schizophr Res"},{"key":"3632_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/npjschz.2016.20","volume":"2","author":"M Kirschner","year":"2016","unstructured":"Kirschner M, Hager OM, Bischof M, Hartmann-Riemer MN, Kluge A, Seifritz E, et al. Deficits in context-dependent adaptive coding of reward in schizophrenia. NPJ Schizophr. 2016;2:16020.","journal-title":"NPJ Schizophr"},{"key":"3632_CR67","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00213-012-2771-4","volume":"222","author":"CM Bradshaw","year":"2012","unstructured":"Bradshaw CM, Killeen PR. A theory of behaviour on progressive ratio schedules, with applications in behavioural pharmacology. Psychopharmacology (Berl). 2012;222:549\u201364.","journal-title":"Psychopharmacology (Berl)"},{"key":"3632_CR68","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/schbul\/sbv226","volume":"42","author":"LF Reddy","year":"2016","unstructured":"Reddy LF, Waltz JA, Green MF, Wynn JK, Horan WP. Probabilistic reversal learning in schizophrenia: stability of deficits and potential causal mechanisms. Schizophr Bull. 2016;42:942\u201351.","journal-title":"Schizophr Bull"},{"key":"3632_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/schbul\/sbv075","volume":"42","author":"AJ Culbreth","year":"2016","unstructured":"Culbreth AJ, Gold JM, Cools R, Barch DM. Impaired activation in cognitive control regions predicts reversal learning in schizophrenia. Schizophr Bull. 2016;42:484\u201393.","journal-title":"Schizophr Bull"},{"key":"3632_CR70","unstructured":"Rescorla RA, & Wagner, A.R. A theory of pavlovian conditioning: variations in the effectiveness of reinforcement and non reinforcement. In: Black AH (ed). Classical condtitioning II Current theory and research. Appleton-Century-Crofts: New York, 1972."},{"key":"3632_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/schbul\/sbi005","volume":"31","author":"RE Lubow","year":"2005","unstructured":"Lubow RE. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull. 2005;31:139\u201353.","journal-title":"Schizophr Bull"},{"key":"3632_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1037\/0033-2909.117.1.87","volume":"117","author":"RE Lubow","year":"1995","unstructured":"Lubow RE, Gewirtz JC. Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychol Bull. 1995;117:87\u2013103.","journal-title":"Psychol Bull"},{"key":"3632_CR73","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.biopsych.2008.12.007","volume":"65","author":"A Abi-Dargham","year":"2009","unstructured":"Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects. Biol Psychiatry. 2009;65:1091\u20133.","journal-title":"Biol Psychiatry"},{"key":"3632_CR74","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/026988119901300405","volume":"13","author":"M Laruelle","year":"1999","unstructured":"Laruelle M, Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol. 1999;13:358\u201371.","journal-title":"J Psychopharmacol"},{"key":"3632_CR75","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D\u2019Souza CD, Erdos J, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 1996;93:9235\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3632_CR76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2018.06.042","volume":"174","author":"F Sun","year":"2018","unstructured":"Sun F, Zeng J, Jing M, Zhou J, Feng J, Owen SF, et al. A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice. Cell. 2018;174:481\u2013496.e19.","journal-title":"Cell"},{"key":"3632_CR77","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998\u20131007.","journal-title":"Arch Gen Psychiatry"},{"key":"3632_CR78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00427592","volume":"67","author":"B Angrist","year":"1980","unstructured":"Angrist B, Rotrosen J, Gershon S. Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. Psychopharmacology (Berl). 1980;67:31\u201338.","journal-title":"Psychopharmacology (Berl)"},{"key":"3632_CR79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","volume":"74","author":"A Egerton","year":"2013","unstructured":"Egerton A, Chaddock CA, Winton-Brown TT, Bloomfield MA, Bhattacharyya S, Allen P, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry. 2013;74:106\u201312.","journal-title":"Biol Psychiatry"},{"key":"3632_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0920-9964(91)90053-T","volume":"5","author":"J Addington","year":"1991","unstructured":"Addington J, Addington D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophr Res. 1991;5:51\u201359.","journal-title":"Schizophr Res"},{"key":"3632_CR81","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","volume":"39","author":"NC Andreasen","year":"1982","unstructured":"Andreasen NC, Olsen S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry. 1982;39:789\u201394.","journal-title":"Arch Gen Psychiatry"},{"key":"3632_CR82","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"A Breier","year":"1997","unstructured":"Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA. 1997;94:2569\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3632_CR83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00433802","volume":"72","author":"B Angrist","year":"1980","unstructured":"Angrist B, Rotrosen J, Gershon S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Berl). 1980;72:17\u201319.","journal-title":"Psychopharmacology (Berl)"},{"key":"3632_CR84","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/oxfordjournals.schbul.a007125","volume":"30","author":"H Yogev","year":"2004","unstructured":"Yogev H, Sirota P, Gutman Y, Hadar U. Latent inhibition and overswitching in schizophrenia. Schizophr Bull. 2004;30:713\u201326.","journal-title":"Schizophr Bull"},{"key":"3632_CR85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF00216006","volume":"91","author":"JA Lieberman","year":"1987","unstructured":"Lieberman JA, Kane JM, Alvir J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl). 1987;91:415\u201333.","journal-title":"Psychopharmacology (Berl)"},{"key":"3632_CR86","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1126\/science.275.5306.1593","volume":"275","author":"W Schultz","year":"1997","unstructured":"Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997;275:1593\u20139.","journal-title":"Science"},{"key":"3632_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/jn.1998.80.1.1","volume":"80","author":"W Schultz","year":"1998","unstructured":"Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 1998;80:1\u201327.","journal-title":"J Neurophysiol"},{"key":"3632_CR88","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbr.2011.01.052","volume":"220","author":"FJ van der Staay","year":"2011","unstructured":"van der Staay FJ, Rutten K, Erb C, Blokland A. Effects of the cognition impairer MK-801 on learning and memory in mice and rats. Behav Brain Res. 2011;220:215\u201329.","journal-title":"Behav Brain Res"},{"key":"3632_CR89","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.biopsych.2004.11.031","volume":"57","author":"MR Stefani","year":"2005","unstructured":"Stefani MR, Moghaddam B. Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry. 2005;57:433\u20136.","journal-title":"Biol Psychiatry"},{"key":"3632_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.19","volume":"7","author":"K Yasuda","year":"2017","unstructured":"Yasuda K, Hayashi Y, Yoshida T, Kashiwagi M, Nakagawa N, Michikawa T, et al. Schizophrenia-like phenotypes in mice with NMDA receptor ablation in intralaminar thalamic nucleus cells and gene therapy-based reversal in adults. Transl Psychiatry. 2017;7:e1047.","journal-title":"Transl Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03632-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:03:17Z","timestamp":1785981797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03632-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03632-1","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal and other applied procedures were in accordance with the National Institutes of Health guidelines and approved by the Institutional Animal Care and Use Committee at Oregon Health & Science University (protocol IP00000727).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"N\/A study did not involve human subjects.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}